June 9, 2015

July 9, 2015

December 9, 2021

June 9, 2016

Available in North America, injection-moldable reSound™ REC TPEs utilize 9-83% recycled content, and both grades can be overmolded onto polypropylene (PP).

Microsoft PowerPoint - Avient Q4 Earnings and 2021 Outlook PRINT AVIENT CORPORATION F O U R T H Q U A R T E R 2 0 2 0 R E S U L T S A N D 2 0 2 1 F I N A N C I A L G U I D A N C E (NYSE: AVNT) F E B R U A R Y 9 , 2 0 2 1 D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. W H Y AV I E N T W I N S Deep Customer Relationships & Application Know-How Superior Design Capabilities & Advanced Analytics Global Footprint Strategically Aligned to Serve Customers We iterate fast and often. 37 24 10 36 • U.S. and Canada • Latin America • Europe, Middle East & Africa • Asia We produce locally, serve globally. Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 22 Capex / Revenue 2021E (%) AV I E N T I S A SS E T L I G H T Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 2 3 3 6 2 3 4 4 5 5 5 6 6 6 7 9 25 A vi e n t A vi e n t (E xc l.

W H O W E A R E – V I S I O N , S T R AT E G Y, C U LT U R E 3 Avient Corporation (NYSE: AVNT) provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world. W H AT W E D O : M AT E R I A L S C I E N C E 4 CUSTOM FORMULATION We sell solutions not commodities. W H Y AV I E N T W I N S Deep Customer Relationships & Application Know-How Superior Design Capabilities & Advanced Analytics Global Footprint Strategically Aligned to Serve Customers We iterate fast and often. 39 22 9 34 • U.S. and Canada • Latin America • Europe, Middle East & Africa • Asia We produce locally, serve globally.

All Rights Reserved 2025 Color, Additives & Inks E N D M A R K E T S R E G I O N S 34% 21% 15% 11% 9% 8% Packaging Telecom 1%Energy 1% Transportation Industrial Consumer 34% 37% 20% 9% US & Canada Latin America Asia Europe, Middle East and Africa Healthcare Building & Construction 21Copyright © . All Rights Reserved 2025 Specialty Engineered Materials E N D M A R K E T S R E G I O N S 20% 17% 14%13% 9% 9% 7% 7% 4% Defense Packaging Telecom Building & construction Transportation Industrial Consumer 54% 33% 13% US & Canada Asia Europe, Middle East and Africa Energy Healthcare Copyright © . All Rights Reserved 2025 22 Avient 2024 regional sales, by end market U S & C AN AD A 41% of sales E M E A 35% of sales AS I A 18% of sales L AT I N AM E R I C A 6% of sales 13% 22% 14% 9% 13% 10% 9% 6% 4% Packaging TelecomEnergyDefenseHealthcareBuilding & construction TransportationIndustrialConsumer 26% 13% 16% 13% 10% 5% 10% 5% 2% 31% 26% 14% 10% 5% 10% 1% 1% 2% 61% 20% 7% 6% 4% 2% Copyright © .

Infolinia jest dostępna w wielu językach, przez całą dobę i siedem dni w tygodniu. HOME OUR CODE RESPECT FOR ALL HONESTY AT WORK INTEGRITY IN OUR BUSINESS CORPORATE SOCIAL RESPONSIBILITY RESOURCES KODEKS POSTĘPOWANIA | 9 SPIS TREŚCI WSTĘP NASZ KODEKS POSTĘPOWANIA SZACUNEK DLA WSZYSTKICH UCZCIWOŚĆ W PRACY UCZCIWOŚĆ W DZIAŁALNOŚCI BIZNESOWEJ SPOŁECZNA ODPOWIEDZIALNOŚĆ BIZNESU DANE KONTAKTOWE Nadużywanie substancji psychoaktywnych Wszyscy jesteśmy zobowiązani do tego, by podejmować odpowiednie działania, które zapewnią, że będziemy pracować w środowisku, w którym nie spożywa się alkoholu, nie przyjmuje narkotyków ani innych kontrolowanych substancji Avient surowo zabrania nielegalnego posiadania, wytwarzania, dystrybucji, wydawania, sprzedaży oraz spożywania substancji kontrolowanych i narkotyków na terenie spółki (w tym także na parkingach) albo podczas odbywania podróży służbowych (dotyczy to także posiadania, dystrybucji, wydawania, sprzedaży i używania akcesoriów związanych z narkotykami). W związku z tym branie łapówek i nielegalnych prowizji jest zabronione nawet w krajach, w których mogą one być zgodne z prawem.

D is t. ) K W R P P G A V Y F U L R P M G C P H X L F M C H U N IF F E C L A S H K R A E M N C E S C L A L B Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of July 28, 2021 Avient reflects 2021 estimated revenue of $4,650M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 81% Median: 78% H I G H F R E E C A S H F L OW C O N V E R S I O N Avient reflects 2021 estimated EBITDA of $580M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of July 28, 2021 87 90 86 82 80 78 73 87 82 82 79 79 78 78 77 76 71 67 46 A vi e n t K W R P P G A V Y F U L R P M G C P F M C U N V R C E IF F A S H E C L B N R E M N H X L H U N K R A S C L A L B (6) Source: Peer data per Bloomberg market data as of July 28, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the median of other selected chemical / specialty companies. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 25 Avient reflects 2021 estimated EBITDA of $580M O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 9.5 18.5 15.1 15.1 14.0 11.0 10.4 29.5 28.2 23.9 18.7 12.4 12.2 11.1 9.3 9.2 9.2 7.6 7.6 6.0 A vi e n t K W R P P G A V Y R P M F U L G C P A L B H X L E C L IF F F M C B N R A S H S C L E M N U N V R K R A C E H U N Median: 11.1xMedian: 14.6x S U M M A RY: W H Y I N V E S T I N AV I E N T ?